Log in to save to my catalogue

Identification of BCL11A, NTN5, and OGN as Diagnosis Biomarker of Papillary Renal Cell Carcinomas by...

Identification of BCL11A, NTN5, and OGN as Diagnosis Biomarker of Papillary Renal Cell Carcinomas by...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_15586_jkcvhl_v12i1_366

Identification of BCL11A, NTN5, and OGN as Diagnosis Biomarker of Papillary Renal Cell Carcinomas by Bioinformatic Analysis

About this item

Full title

Identification of BCL11A, NTN5, and OGN as Diagnosis Biomarker of Papillary Renal Cell Carcinomas by Bioinformatic Analysis

Journal title

Journal of kidney cancer and VHL, 2025-02, Vol.12 (1), p.12-22

Language

English

Formats

More information

Scope and Contents

Contents

The prevalence of papillary renal cell carcinomas (PRCCs) is estimated to be between 10% and 15%. At present, there is no effective therapeutic approach available for patients with advanced PRCCs. The molecular biomarkers associated with PRCC diagnoses have been rarely studied compared to renal clear cell carcinomas; therefore, the necessity for th...

Alternative Titles

Full title

Identification of BCL11A, NTN5, and OGN as Diagnosis Biomarker of Papillary Renal Cell Carcinomas by Bioinformatic Analysis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_15586_jkcvhl_v12i1_366

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_15586_jkcvhl_v12i1_366

Other Identifiers

ISSN

2203-5826

E-ISSN

2203-5826

DOI

10.15586/jkcvhl.v12i1.366

How to access this item